Please use this identifier to cite or link to this item: http://hdl.handle.net/10311/2178
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDiAngi, Yumi Taylor-
dc.contributor.authorPanozzo, Catherine A.-
dc.contributor.authorRamogola-Masire, Doreen-
dc.contributor.authorSteenhoff, Andrew P.-
dc.contributor.authorBrewer, Noel T.-
dc.date.accessioned2021-10-05T11:37:14Z-
dc.date.available2021-10-05T11:37:14Z-
dc.date.issued2011-10-25-
dc.identifier.citationDiAngi Y.T. et al (2011) A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PLoS ONE, Vol. 6, No. 10, 7p.en_US
dc.identifier.issn1932-6203 (electronic)-
dc.identifier.urihttp://hdl.handle.net/10311/2178-
dc.description.abstractBackground Cervical cancer is the most common cancer among women in Botswana and elsewhere in Sub-Saharan Africa. We sought to examine whether HPV vaccine is acceptable among parents in Botswana, which recently licensed the vaccine to prevent cervical cancer. Methods and Findings We conducted a cross-sectional survey in 2009, around the time the vaccine was first licensed, with adults recruited in general medicine and HIV clinics in Gaborone, the capital of Botswana. Although only 9% (32/376) of respondents had heard of HPV vaccine prior to the survey, 88% (329/376) said they definitely will have their adolescent daughters receive HPV vaccine. Most respondents would get the vaccine for their daughters at a public or community clinic (42%) or a gynecology or obstetrician's office (39%), and 74% would get it for a daughter if it were available at her school. Respondents were more likely to say that they definitely will get HPV vaccine for their daughters if they had less education (OR = 0.20, 95% CI = 0.07–0.58) or lived more than 30 kilometers from the capital, Gaborone (OR = 2.29, 95% CI = 1.06–4.93). Other correlates of acceptability were expecting to be involved in the decision to get HPV vaccine, thinking the vaccine would be hard to obtain, and perceiving greater severity of HPV-related diseases. Conclusions HPV vaccination of adolescent girls would be highly acceptable if the vaccine became widely available to the daughters of healthcare-seeking parents in Gaborone, Botswana. Potential HPV vaccination campaigns should provide more information about HPV and the vaccine as well as work to minimize barriers.en_US
dc.description.sponsorshipThis study was made possible through core services and support from the Penn Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program (P30 AI 045008). Additional support for publication of the findings was provided by a grant from the American Cancer Society (MSRG-06-259-01-CPPB).en_US
dc.language.isoenen_US
dc.publisherPublic Library of Science, http://www.plosone.org/en_US
dc.rightsThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.subjectCervical canceren_US
dc.subjectHPV vaccineen_US
dc.subjectAdolescent girlsen_US
dc.subjectBotswanaen_US
dc.titleA cross-sectional study of HPV vaccine acceptability in Gaborone, Botswanaen_US
dc.typePublished Articleen_US
dc.rights.holder2011 DiAngi et alen_US
dc.linkhttps://doi.org/10.1371/journal.pone.0025481en_US
Appears in Collections:Research articles (School of Medicine)



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.